Cargando…
Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma
BACKGROUND: To explore the effective dose to immune cells (EDIC) for better prognosis while avoiding radiation-induced lymphopenia (RIL) in patients with locally advanced esophageal squamous cell carcinoma (ESCC). MATERIALS AND METHODS: Overall, 381 patients with locally advanced ESCC receiving defi...
Autores principales: | Qiu, Jianjian, Lin, Hancui, Ke, Dongmei, Yu, Yilin, Xu, Jiaying, Qiu, Hejin, Zheng, Qunhao, Li, Hui, Zheng, Hongying, Liu, Lingyun, Wang, Zhiping, Yao, Qiwei, Li, Jiancheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10200938/ https://www.ncbi.nlm.nih.gov/pubmed/37223094 http://dx.doi.org/10.3389/fimmu.2023.1066255 |
Ejemplares similares
-
Using inflammatory indexes and clinical parameters to predict radiation esophagitis in patients with small-cell lung cancer undergoing chemoradiotherapy
por: Qiu, Jianjian, et al.
Publicado: (2022) -
Prognostic value of pre-therapeutic nutritional risk factors in elderly patients with locally advanced esophageal squamous cell carcinoma receiving definitive chemoradiotherapy or radiotherapy
por: Qiu, Jianjian, et al.
Publicado: (2023) -
A New Nomogram and Risk Stratification of Brain Metastasis by Clinical and Inflammatory Parameters in Stage III Small Cell Lung Cancer Without Prophylactic Cranial Irradiation
por: Qiu, Jianjian, et al.
Publicado: (2022) -
The novel pretreatment immune prognostic index discriminates survival outcomes in locally advanced non-operative esophageal squamous cell carcinoma patients treated with definitive chemoradiotherapy: a 6-year retrospective study
por: Yu, Yilin, et al.
Publicado: (2022) -
Predicting Severe Radiation Esophagitis in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma Receiving Definitive Chemoradiotherapy: Construction and Validation of a Model Based in the Clinical and Dosimetric Parameters as Well as Inflammatory Indexes
por: Yu, Yilin, et al.
Publicado: (2021)